APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol and Ciprofol Injections

Compare research editions
View pricing & licenses

Selected research

Industry Research

Propofol and Ciprofol Injections Industry Research Report 2026

22 December 2025138 pages

Choose your research edition.

Industry ResearchPropofol and Ciprofol Injections Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol and Ciprofol Injections Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Propofol and Ciprofol Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol and Ciprofol Injections Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol and Ciprofol Injections Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Propofol and Ciprofol Injections market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Propofol and Ciprofol Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Propofol and Ciprofol Injections is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Propofol and Ciprofol Injections is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Propofol and Ciprofol Injections include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Haisco Pharmaceutical Group, Jiangsu Yingke Biopharmaceutical, Pfizer, Guangdong Jiabo Pharmaceutical, Fresenius Kabi, Jiangsu Nhwa Pharmaceutical and B. Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Propofol and Ciprofol Injections market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Propofol and Ciprofol Injections Market by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Haisco Pharmaceutical Group

Jiangsu Yingke Biopharmaceutical

Pfizer

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Jiangsu Nhwa Pharmaceutical

B. Braun

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

AstraZeneca

Wellona Pharma

Rusoma

NEON

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

Propofol and Ciprofol Injections Segment by Type

Propofol Injections

Ciprofol Injections

Propofol and Ciprofol Injections Segment by Application

Gastrointestinal Endoscopy

Anesthesia for Surgery

Other

Propofol and Ciprofol Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol and Ciprofol Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol and Ciprofol Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol and Ciprofol Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Propofol and Ciprofol Injections manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Propofol and Ciprofol Injections by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Propofol and Ciprofol Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Propofol and Ciprofol Injections Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Propofol and Ciprofol Injections Sales (k units) of Manufacturers (2021-2026) Table 7. Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers (2021-2026) Table 8. Global Propofol and Ciprofol Injections Revenue of Manufacturers (2021-2026) Table 9. Global Propofol and Ciprofol Injections Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Propofol and Ciprofol Injections Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Propofol and Ciprofol Injections Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Propofol and Ciprofol Injections, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Propofol and Ciprofol Injections, Product Type & Application Table 14. Global Propofol and Ciprofol Injections Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Propofol and Ciprofol Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Xi’an Libang Pharmaceutical Company Information Table 19. Xi’an Libang Pharmaceutical Business Overview Table 20. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 22. Xi’an Libang Pharmaceutical Recent Developments Table 23. Sichuan Kelun Pharmaceutical Company Information Table 24. Sichuan Kelun Pharmaceutical Business Overview Table 25. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 27. Sichuan Kelun Pharmaceutical Recent Developments Table 28. Haisco Pharmaceutical Group Company Information Table 29. Haisco Pharmaceutical Group Business Overview Table 30. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio Table 32. Haisco Pharmaceutical Group Recent Developments Table 33. Jiangsu Yingke Biopharmaceutical Company Information Table 34. Jiangsu Yingke Biopharmaceutical Business Overview Table 35. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 37. Jiangsu Yingke Biopharmaceutical Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Pfizer Propofol and Ciprofol Injections Product Portfolio Table 42. Pfizer Recent Developments Table 43. Guangdong Jiabo Pharmaceutical Company Information Table 44. Guangdong Jiabo Pharmaceutical Business Overview Table 45. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 47. Guangdong Jiabo Pharmaceutical Recent Developments Table 48. Fresenius Kabi Company Information Table 49. Fresenius Kabi Business Overview Table 50. Fresenius Kabi Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio Table 52. Fresenius Kabi Recent Developments Table 53. Jiangsu Nhwa Pharmaceutical Company Information Table 54. Jiangsu Nhwa Pharmaceutical Business Overview Table 55. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 57. Jiangsu Nhwa Pharmaceutical Recent Developments Table 58. B. Braun Company Information Table 59. B. Braun Business Overview Table 60. B. Braun Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. B. Braun Propofol and Ciprofol Injections Product Portfolio Table 62. B. Braun Recent Developments Table 63. Beijing Sciecure Pharmaceutical Company Information Table 64. Beijing Sciecure Pharmaceutical Business Overview Table 65. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 67. Beijing Sciecure Pharmaceutical Recent Developments Table 68. Sichuan Biokin Pharmaceutical Company Information Table 69. Sichuan Biokin Pharmaceutical Business Overview Table 70. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 72. Sichuan Biokin Pharmaceutical Recent Developments Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. AstraZeneca Propofol and Ciprofol Injections Product Portfolio Table 77. AstraZeneca Recent Developments Table 78. Wellona Pharma Company Information Table 79. Wellona Pharma Business Overview Table 80. Wellona Pharma Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Wellona Pharma Propofol and Ciprofol Injections Product Portfolio Table 82. Wellona Pharma Recent Developments Table 83. Rusoma Company Information Table 84. Rusoma Business Overview Table 85. Rusoma Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Rusoma Propofol and Ciprofol Injections Product Portfolio Table 87. Rusoma Recent Developments Table 88. NEON Company Information Table 89. NEON Business Overview Table 90. NEON Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. NEON Propofol and Ciprofol Injections Product Portfolio Table 92. NEON Recent Developments Table 93. Flagship Biotech Company Information Table 94. Flagship Biotech Business Overview Table 95. Flagship Biotech Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Flagship Biotech Propofol and Ciprofol Injections Product Portfolio Table 97. Flagship Biotech Recent Developments Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Developments Table 103. Centurion Healthcare Company Information Table 104. Centurion Healthcare Business Overview Table 105. Centurion Healthcare Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio Table 107. Centurion Healthcare Recent Developments Table 108. Global Propofol and Ciprofol Injections Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Propofol and Ciprofol Injections Sales by Region (2021-2026) & (k units) Table 110. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026) Table 111. Global Propofol and Ciprofol Injections Sales by Region (2027-2032) & (k units) Table 112. Global Propofol and Ciprofol Injections Sales Market Share by Region (2027-2032) Table 113. Global Propofol and Ciprofol Injections Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2026) Table 115. Global Propofol and Ciprofol Injections Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2027-2032) Table 117. North America Propofol and Ciprofol Injections Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 119. North America Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 120. North America Propofol and Ciprofol Injections Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Propofol and Ciprofol Injections Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Propofol and Ciprofol Injections Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 124. Europe Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 125. Europe Propofol and Ciprofol Injections Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Propofol and Ciprofol Injections Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Propofol and Ciprofol Injections Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Propofol and Ciprofol Injections Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Propofol and Ciprofol Injections Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Propofol and Ciprofol Injections Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 134. South America Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 135. South America Propofol and Ciprofol Injections Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Propofol and Ciprofol Injections Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 143. Global Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 144. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026) Table 145. Global Propofol and Ciprofol Injections Sales Market Share by Type (2027-2032) Table 146. Global Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026) Table 149. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2027-2032) Table 150. Global Propofol and Ciprofol Injections Price by Type (2021-2026) & (US$/unit) Table 151. Global Propofol and Ciprofol Injections Price by Type (2027-2032) & (US$/unit) Table 152. Global Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 153. Global Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 154. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026) Table 155. Global Propofol and Ciprofol Injections Sales Market Share by Application (2027-2032) Table 156. Global Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2026) Table 159. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2027-2032) Table 160. Global Propofol and Ciprofol Injections Price by Application (2021-2026) & (US$/unit) Table 161. Global Propofol and Ciprofol Injections Price by Application (2027-2032) & (US$/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Propofol and Ciprofol Injections Distributors List Table 165. Propofol and Ciprofol Injections Customers List Table 166. Propofol and Ciprofol Injections Industry Trends Table 167. Propofol and Ciprofol Injections Industry Drivers Table 168. Propofol and Ciprofol Injections Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Propofol and Ciprofol Injections Product Image Figure 5. Global Propofol and Ciprofol Injections Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Propofol and Ciprofol Injections Market Size (2021-2032) & (US$ Million) Figure 7. Global Propofol and Ciprofol Injections Sales (2021-2032) & (k units) Figure 8. Global Propofol and Ciprofol Injections Average Price (US$/unit) & (2021-2032) Figure 9. Propofol Injections Product Image Figure 10. Ciprofol Injections Product Image Figure 11. Gastrointestinal Endoscopy Product Image Figure 12. Anesthesia for Surgery Product Image Figure 13. Other Product Image Figure 14. Global Propofol and Ciprofol Injections Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Propofol and Ciprofol Injections, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Propofol and Ciprofol Injections Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Propofol and Ciprofol Injections Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Propofol and Ciprofol Injections Sales by Region in 2025 Figure 20. Global Propofol and Ciprofol Injections Revenue by Region in 2025 Figure 21. North America Propofol and Ciprofol Injections Market Size by Country in 2025 Figure 22. North America Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 23. North America Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2032) Figure 24. United States Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Propofol and Ciprofol Injections Market Size by Country in 2025 Figure 28. Europe Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 29. Europe Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2032) Figure 30. Germany Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Propofol and Ciprofol Injections Market Size by Country in 2025 Figure 41. Asia Pacific Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2032) Figure 43. China Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Propofol and Ciprofol Injections Market Size by Country in 2025 Figure 52. South America Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 53. South America Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2032) Figure 54. Brazil Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Propofol and Ciprofol Injections Market Size by Country in 2025 Figure 58. Middle East and Africa Propofol and Ciprofol Injections Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Propofol and Ciprofol Injections Revenue Market Share by Country (2021-2032) Figure 60. Egypt Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Propofol and Ciprofol Injections Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032) Figure 66. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032) Figure 67. Global Propofol and Ciprofol Injections Price (US$/unit) by Type (2021-2032) Figure 68. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032) Figure 69. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032) Figure 70. Global Propofol and Ciprofol Injections Price (US$/unit) by Application (2021-2032) Figure 71. Propofol and Ciprofol Injections Value Chain Figure 72. Propofol and Ciprofol Injections Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Propofol and Ciprofol Injections Industry Opportunities and Challenges

Scope & coverage.

Types
  • Propofol Injections
  • Ciprofol Injections
Applications
  • Gastrointestinal Endoscopy
  • Anesthesia for Surgery
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Haisco Pharmaceutical Group
  • Jiangsu Yingke Biopharmaceutical
  • Pfizer
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Jiangsu Nhwa Pharmaceutical
  • B. Braun
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • AstraZeneca
  • Wellona Pharma
  • Rusoma
  • NEON
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Propofol and Ciprofol Injections Market Size (2021-2032)
  4. 2.2.2 Global Propofol and Ciprofol Injections Sales (2021-2032)
  5. 2.2.3 Global Propofol and Ciprofol Injections Market Average Price (2021-2032)
  6. 2.3 Propofol and Ciprofol Injections by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Propofol Injections
  9. 2.3.3 Ciprofol Injections
  10. 2.4 Propofol and Ciprofol Injections by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Gastrointestinal Endoscopy
  13. 2.4.3 Anesthesia for Surgery
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Propofol and Ciprofol Injections Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Propofol and Ciprofol Injections Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Propofol and Ciprofol Injections Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Propofol and Ciprofol Injections Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Propofol and Ciprofol Injections Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Propofol and Ciprofol Injections, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Propofol and Ciprofol Injections, Product Type & Application
  8. 3.8 Global Manufacturers of Propofol and Ciprofol Injections, Established Date
  9. 3.9 Global Propofol and Ciprofol Injections Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Xi’an Libang Pharmaceutical
  2. 4.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 4.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 4.1.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  6. 4.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 4.2 Sichuan Kelun Pharmaceutical
  8. 4.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 4.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 4.2.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  12. 4.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 4.3 Haisco Pharmaceutical Group
  14. 4.3.1 Haisco Pharmaceutical Group Company Information
  15. 4.3.2 Haisco Pharmaceutical Group Business Overview
  16. 4.3.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio
  18. 4.3.5 Haisco Pharmaceutical Group Recent Developments
  19. 4.4 Jiangsu Yingke Biopharmaceutical
  20. 4.4.1 Jiangsu Yingke Biopharmaceutical Company Information
  21. 4.4.2 Jiangsu Yingke Biopharmaceutical Business Overview
  22. 4.4.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio
  24. 4.4.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Propofol and Ciprofol Injections Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 Guangdong Jiabo Pharmaceutical
  32. 4.6.1 Guangdong Jiabo Pharmaceutical Company Information
  33. 4.6.2 Guangdong Jiabo Pharmaceutical Business Overview
  34. 4.6.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  36. 4.6.5 Guangdong Jiabo Pharmaceutical Recent Developments
  37. 4.7 Fresenius Kabi
  38. 4.7.1 Fresenius Kabi Company Information
  39. 4.7.2 Fresenius Kabi Business Overview
  40. 4.7.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio
  42. 4.7.5 Fresenius Kabi Recent Developments
  43. 4.8 Jiangsu Nhwa Pharmaceutical
  44. 4.8.1 Jiangsu Nhwa Pharmaceutical Company Information
  45. 4.8.2 Jiangsu Nhwa Pharmaceutical Business Overview
  46. 4.8.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  48. 4.8.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  49. 4.9 B. Braun
  50. 4.9.1 B. Braun Company Information
  51. 4.9.2 B. Braun Business Overview
  52. 4.9.3 B. Braun Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 B. Braun Propofol and Ciprofol Injections Product Portfolio
  54. 4.9.5 B. Braun Recent Developments
  55. 4.10 Beijing Sciecure Pharmaceutical
  56. 4.10.1 Beijing Sciecure Pharmaceutical Company Information
  57. 4.10.2 Beijing Sciecure Pharmaceutical Business Overview
  58. 4.10.3 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  60. 4.10.5 Beijing Sciecure Pharmaceutical Recent Developments
  61. 4.11 Sichuan Biokin Pharmaceutical
  62. 4.11.1 Sichuan Biokin Pharmaceutical Company Information
  63. 4.11.2 Sichuan Biokin Pharmaceutical Business Overview
  64. 4.11.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  66. 4.11.5 Sichuan Biokin Pharmaceutical Recent Developments
  67. 4.12 AstraZeneca
  68. 4.12.1 AstraZeneca Company Information
  69. 4.12.2 AstraZeneca Business Overview
  70. 4.12.3 AstraZeneca Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 AstraZeneca Propofol and Ciprofol Injections Product Portfolio
  72. 4.12.5 AstraZeneca Recent Developments
  73. 4.13 Wellona Pharma
  74. 4.13.1 Wellona Pharma Company Information
  75. 4.13.2 Wellona Pharma Business Overview
  76. 4.13.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Wellona Pharma Propofol and Ciprofol Injections Product Portfolio
  78. 4.13.5 Wellona Pharma Recent Developments
  79. 4.14 Rusoma
  80. 4.14.1 Rusoma Company Information
  81. 4.14.2 Rusoma Business Overview
  82. 4.14.3 Rusoma Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Rusoma Propofol and Ciprofol Injections Product Portfolio
  84. 4.14.5 Rusoma Recent Developments
  85. 4.15 NEON
  86. 4.15.1 NEON Company Information
  87. 4.15.2 NEON Business Overview
  88. 4.15.3 NEON Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 NEON Propofol and Ciprofol Injections Product Portfolio
  90. 4.15.5 NEON Recent Developments
  91. 4.16 Flagship Biotech
  92. 4.16.1 Flagship Biotech Company Information
  93. 4.16.2 Flagship Biotech Business Overview
  94. 4.16.3 Flagship Biotech Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Flagship Biotech Propofol and Ciprofol Injections Product Portfolio
  96. 4.16.5 Flagship Biotech Recent Developments
  97. 4.17 Dr. Reddy's Laboratories
  98. 4.17.1 Dr. Reddy's Laboratories Company Information
  99. 4.17.2 Dr. Reddy's Laboratories Business Overview
  100. 4.17.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio
  102. 4.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 4.18 Centurion Healthcare
  104. 4.18.1 Centurion Healthcare Company Information
  105. 4.18.2 Centurion Healthcare Business Overview
  106. 4.18.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio
  108. 4.18.5 Centurion Healthcare Recent Developments
5 Global Propofol and Ciprofol Injections Market Scenario by Region
  1. 5.1 Global Propofol and Ciprofol Injections Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Propofol and Ciprofol Injections Sales by Region: 2021-2032
  3. 5.2.1 Global Propofol and Ciprofol Injections Sales by Region: 2021-2026
  4. 5.2.2 Global Propofol and Ciprofol Injections Sales by Region: 2027-2032
  5. 5.3 Global Propofol and Ciprofol Injections Revenue by Region: 2021-2032
  6. 5.3.1 Global Propofol and Ciprofol Injections Revenue by Region: 2021-2026
  7. 5.3.2 Global Propofol and Ciprofol Injections Revenue by Region: 2027-2032
  8. 5.4 North America Propofol and Ciprofol Injections Market Facts & Figures by Country
  9. 5.4.1 North America Propofol and Ciprofol Injections Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Propofol and Ciprofol Injections Sales by Country (2021-2032)
  11. 5.4.3 North America Propofol and Ciprofol Injections Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Propofol and Ciprofol Injections Market Facts & Figures by Country
  16. 5.5.1 Europe Propofol and Ciprofol Injections Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Propofol and Ciprofol Injections Sales by Country (2021-2032)
  18. 5.5.3 Europe Propofol and Ciprofol Injections Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Propofol and Ciprofol Injections Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Propofol and Ciprofol Injections Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Propofol and Ciprofol Injections Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Propofol and Ciprofol Injections Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Propofol and Ciprofol Injections Market Facts & Figures by Country
  41. 5.7.1 South America Propofol and Ciprofol Injections Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Propofol and Ciprofol Injections Sales by Country (2021-2032)
  43. 5.7.3 South America Propofol and Ciprofol Injections Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Propofol and Ciprofol Injections Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Propofol and Ciprofol Injections Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Propofol and Ciprofol Injections Sales by Type (2021-2032)
  2. 6.1.1 Global Propofol and Ciprofol Injections Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032)
  4. 6.2 Global Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  5. 6.2.1 Global Propofol and Ciprofol Injections Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Propofol and Ciprofol Injections Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Propofol and Ciprofol Injections Sales by Application (2021-2032)
  2. 7.1.1 Global Propofol and Ciprofol Injections Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032)
  4. 7.2 Global Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  5. 7.2.1 Global Propofol and Ciprofol Injections Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Propofol and Ciprofol Injections Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Propofol and Ciprofol Injections Value Chain Analysis
  2. 8.1.1 Propofol and Ciprofol Injections Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Propofol and Ciprofol Injections Production Mode & Process
  5. 8.2 Propofol and Ciprofol Injections Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Propofol and Ciprofol Injections Distributors
  8. 8.2.3 Propofol and Ciprofol Injections Customers
9 Global Propofol and Ciprofol Injections Analyzing Market Dynamics
  1. 9.1 Propofol and Ciprofol Injections Industry Trends
  2. 9.2 Propofol and Ciprofol Injections Industry Drivers
  3. 9.3 Propofol and Ciprofol Injections Industry Opportunities and Challenges
  4. 9.4 Propofol and Ciprofol Injections Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst